Percutaneous Coronary Intervention clinical trials at UCLA

1 research study open to eligible people

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment
open to eligible people ages 18 years and up
To test whether FFRangio-guided treatment is non-inferior to conventional pressure wire-guided treatment in patients with coronary artery disease.
Los Angeles, California and other locations

Last updated: November 7, 2024